You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The researchers used the tool to look at the role of miRNAs in viral infection, but believe it has potential for studying miRNA in many other contexts.
The company will work with the investigators to examine whether levels of the microRNA can predict patient outcomes to different anti-EGRF therapies.
Members of TCGA characterized papillary renal cell carcinomas, uncovering two main tumor groups and several more prognostically informative subtypes.
In Nature this week: how CRISPR/Cas9 homes in on target, miRNAs involved in cholesterol and triglyceride regulation, and more.
The firm’s increase in sales included a 25 percent jump in sales of Rosetta's core microRNA-based diagnostic assays over the first half of 2014.
The International Thyroid Congress and Annual Meeting of the American Thyroid Association announced studies validating diagnostics tests for several companies.
In Cell this week: method to examine DNA methylation patterns, molecular features of lobular breast cancer, and more.
In PNAS this week: genome and transcriptome of the Asian tiger mosquito, TB diversity and virulence in Inuit populations, and more.
The company plans to establish a clinical laboratory to offer its Gensignia miRNA Signature Classifier for Lung Cancer Test, as well as other tests in the future.
Researchers characterized more than 800 breast tumors using whole-exome sequencing, RNA sequencing, miRNA sequencing, and other methods.
President Donald Trump announced the US would be leaving the World Health Organization, NBC News reports.
A study of Great Danes homes in on a genomic region linked to fearfulness.
CDC head says a new analysis indicates earlier testing wouldn't have caught viral spread, NPR reports.
In PLOS this week: gene expression and epigenetics of Indonesian populations, hookworm parasite secretome, and more.